Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2021-04-02 | 2021-04-02 |
| Drug Identification Number | 02130955 | 02130955 |
| Brand name | TYPHIM VI | TYPHIM VI |
| Common or Proper name | Salmonella typhi Vi Capsular Polysaccharide Vaccine | Salmonella typhi Vi Capsular Polysaccharide Vaccine |
| Company Name | SANOFI PASTEUR LIMITED | SANOFI PASTEUR LIMITED |
| Ingredients | SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE | SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE |
| Strength(s) | 25MCG | 25MCG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10 mL multidose vial (20 Doses) | 10 mL multidose vial (20 Doses) |
| ATC code | J07AP | J07AP |
| ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2021-04-01 | 2021-04-01 |
| Actual discontinuation date | 2021-04-01 | 2021-04-01 |
| Remaining supply date | 2021-04-01 | 2021-04-01 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Sanofi Pasteur will be discontinuing the multidose vial presentation of Typhim Vi ® vaccine effective April 1st 2021. The single dose syringe presentation of Typhim Vi® will still be available to the market. | Sanofi Pasteur will be discontinuing the multidose vial presentation of Typhim Vi ® vaccine effective April 1st 2021. The single dose syringe presentation of Typhim Vi® will still be available to the market. |
| Health Canada comments |